Walker et al., 2009 - Google Patents
Stability of preoperative cataract surgery gel in polycarbonate syringesWalker et al., 2009
- Document ID
- 812476606681787393
- Author
- Walker B
- Ben M
- McGuire J
- Publication year
- Publication venue
- International Journal of Pharmaceutical Compounding
External Links
Snippet
The stability of preoperative cataract surgery gel packaged in 1-mL polycarbonate syringes, stored protected from light under controlled temperatures for a period of 60 days, was studied. Preoperative cataract surgery gel is a mixture of cyclopentolate hydrochloride 0.51 …
- 208000002177 Cataract 0 title abstract description 41
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
- A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109157503B (en) | The pharmaceutical composition and its medical usage for preventing and treating NITM | |
| CN110934816B (en) | Method for improving stability of low-concentration atropine ophthalmic preparation | |
| CN105392494A (en) | Chimeric cytokine formulations for ocular delivery | |
| KR102663319B1 (en) | Oxymetazoline Compositions and Methods for Treating Ocular Disorders | |
| Richdale et al. | Compounded 0.01% atropine—what's in the bottle? | |
| Richdale et al. | Compounding of low-concentration atropine for myopia control | |
| Lai et al. | Role of 7-methylxanthine in myopia prevention and control: a mini-review | |
| Walker et al. | Stability of preoperative cataract surgery gel in polycarbonate syringes | |
| EP0213091A1 (en) | Use of compounds for the manufacture of a medicament for the treatment of cataract | |
| Dreno et al. | Formulation and stability study of a pediatric 2% phenylephrine hydrochloride eye drop solution | |
| CN104546698B (en) | Busulfan parenteral solution and preparation method | |
| KR20230051130A (en) | Method and composition for preventing and treating myopia using levocabastine, a selective histamine H1-receptor antagonist, and derivatives thereof | |
| World Health Organization | WHO Pharmaceuticals Newsletter: No. 2, 2022 | |
| Alaula et al. | Atropine toxicity caused by erroneous intranasal administration in a pediatric patient: case report | |
| CN116211796A (en) | Litaset eye drops and preparation method thereof | |
| US20230124124A1 (en) | Compositions and methods for myopia control and orthokeratology lenses treatment | |
| Mohamed-Ahmed et al. | Local production of eye drops in the hospital or pharmacy setting: considerations and safety tips | |
| EP4311551A1 (en) | Low-concentration atropine for myopia prevention (lamp-2) study | |
| KR20230051152A (en) | Method and composition for the prevention and treatment of myopia using β2-adrenoceptor agonist fenoterol hydrobromide and its derivatives | |
| IL299009A (en) | Methods and compositions for preventing and treating myopia with berberine, a berberidaceaen alkaloid, and derivatives thereof | |
| KR20230051154A (en) | Method and composition for the prevention and treatment of myopia using fingolimod, a sphingosine-1-phosphate receptor modulator, and derivatives thereof | |
| EP4389131A1 (en) | Pharmaceutical composition, preparation method therefor and application thereof | |
| WO2021252719A1 (en) | Methods and compositions for preventing and treating myopia with s-methyl-l-thiocitrulline, a selective neuronal nitric oxide synthase (nnos) inhibitor, and derivatives thereof | |
| IL298982A (en) | Methods and compositions for preventing and treating myopia with trichostatin a, a histone deacetylase (hdac) inhibitor, and derivatives thereof | |
| CN110876746A (en) | Ginkgo diterpene lactone eye preparation and preparation method and application thereof |